Kineta, Inc.
Kineta, Inc. (KA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KA · as of Jun 9, 2026
Key Statistics
Explore Kineta, Inc. Data
ka stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
ka competitorsKA
BIOR
CSCI
ENTO
EPIX
FRTXStock Performance
Full HistoryAbout Kineta, Inc.
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships wi…
what is kineta, inc. · ka stock overview · kineta, inc. company profile · who is kineta, inc. ceo · ka NASDAQ · kineta, inc. headquarters · kineta, inc. business segments
About Stock Overview & Key Data
Kineta, Inc. (KA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 11, 2016. As of the latest trading session, KA stock price is $0.57, with a market capitalization of $7.0M. The stock has returned -83.49% over the past 12 months and -83.10% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Kineta, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2024, Kineta, Inc. reported revenue of — and net income of -$17.1M. For detailed data — including Kineta, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Kineta, Inc. (KA) stock price is $0.57. The stock is traded on NASDAQ under the ticker symbol KA. The 52-week range is $0.33 – $5.39.